In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and ...
All content for The ConcertAI Podcast is the property of ConcertAI and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and ...
On our first episode, special guest Claudio D'Ambrosio covers the topic of multi-modal data in biomedical research. Multi-modal data can allow some of the deepest most advanced research questions to be answered. We start with the questions and then we bring together layers of different data, of different origin, that surround the patient in service of that particular question. This will change and transform how we develop and test hypothesis and will accelerate early phase trial activities.&n...
The ConcertAI Podcast
In this episode, ConcertAI CEO Jeff Elton sits down with Mike Rossi, PhD - ConcertAI's Clinical Genomics Lead - to explore how real-world genomic and clinical data are transforming early-stage oncology research. From the evolution of next-generation sequencing to liquid biopsy innovations, they unpack how integrated data sources are helping biopharma optimize study design, reduce trial risk, and accelerate breakthroughs. With insights into AI-powered simulations, patient journey mapping, and ...
